After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 34.56% to $13.20 in after-hours trading.
Cyclacel Pharmaceuticals Stock Up 34.6% In Massive After-Hours Rally
Where Today's News Shapes Tomorrow
